Celgene Investor
Celgene discovers, develops and commercializes innovative therapies to treat cancer and immune-inflammatory-related diseases.
Invests into
%20.jpg)
%20.jpg)
Founded Date:
1986-01-01
Investor Type:
Not Classified
Employee Number:
8.85K
Funding Status:
M&A
Number Of Exists:
31
Technology:
Pharma
Acquisitions Number:
Made Acquisitions, Was Acquired
Investors Number:
65
Industry:
Biotechnology, Medical
Headquarters:
Summit, New Jersey, United States
Estimated Revenue:
$10B+